Phi Therapeutics
San Francisco, US · Delaware corporation
Founders & leadership
MS
Maria S. ChoNamed on SEC filing
YV
Yug VarmaNamed on SEC filing
JL
Jun LiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 3 rounds · 2019–2023
▶$7.7MraisedJun 2024 · 22 investors · BiotechnologyRule 506(b)
▶$7.7MraisedJun 2024 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JUN LIDirector
- YUG VARMAExecutive Officer, Director
- NEIL GIUGNOExecutive Officer, Director
- KEVIN LAWDirector
- Offering amount
- $7.7M
- Amount sold
- $7.7M
- Minimum investment
- $10K
- Proceeds to insiders
- $181.2K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$660KraisedJan 2022 · 7 investors · BiotechnologyRule 506(b)
▶$660KraisedJan 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jun LiDirector
- Yug VarmaExecutive Officer, Director, Promoter
- Maria ChoDirector, Promoter
- Offering amount
- $2M
- Amount sold
- $660K
- Minimum investment
- $10K
- Proceeds to insiders
- $50K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$575KraisedJun 2019 · 4 investors · BiotechnologyRule 506(b)
▶$575KraisedJun 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Maria S. ChoExecutive Officer, Director
- Yug VarmaExecutive Officer, Director
- Jun LiDirector
- Offering amount
- $1.6M
- Amount sold
- $575K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $164.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Phi Therapeutics raised?
- Phi Therapeutics has disclosed $8.9M raised across 3 rounds.
- Where is Phi Therapeutics headquartered?
- Phi Therapeutics is headquartered in San Francisco, US.